Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
- 17 July 2024
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (10) , 1477-1479
Abstract
No abstract availableKeywords
Funding Information
- COST (European Cooperation in Science and Technology, www.cost.eu) - COST Action 17138 EUROGRAFT
This publication has 12 references indexed in Scilit:
- Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE StudyJournal of Clinical Oncology, 2023
- Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II StudyJournal of Clinical Oncology, 2023
- Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2020
- Reliability and Validity of the Modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom ScaleTransplantation and Cellular Therapy, 2020
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group ReportTransplantation and Cellular Therapy, 2017
- Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian PopulationTransplantation and Cellular Therapy, 2016
- Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive InterviewsTransplantation and Cellular Therapy, 2016
- Reporting of Patient-Reported Outcomes in Randomized TrialsJAMA, 2013
- The Translation and Cultural Adaptation of Patient-Reported Outcome MeasuresValue in Health, 2005
- Improving Primary Care for Patients With Chronic IllnessJAMA, 2002